How can the EU support sustainable innovation and access to effective antibiotics? Policy options for existing and new medicines / Anderson, Michael;Panteli, Dimitra;Mossialos, Elias

Tác giả : Anderson, Michael;Panteli, Dimitra;Mossialos, Elias

Nhà xuất bản : World Health Organization. Regional Office for Europe.

Năm xuất bản : 2023

Tùng thư : Health Systems and Policy Analysis

Chủ đề : 1. Anti-Bacterial Agents. 2. Biomedical Research. 3. Drug Resistance, Bacterial. 4. Drug Resistance, Microbial. 5. Health Policy. 6. Publications.

Thông tin chi tiết

Tóm tắt :

71 p. Antimicrobial and particularly antibiotic resistance is one of the biggest public health challenges the world faces. Over 1 million years of life are lost each year in the European Union (EU)/European Economic Area (EEA) alone due to antibiotic resistance, and it costs healthcare systems about €1.1 billion annually. These health and economic impacts are expected to worsen. Urgent steps are needed and this policy brief focuses on one area where the EU and its Member States can take effective action, fostering sustainable innovation and improving access to effective antibiotics:1. Scientific, economic, structural and regulatory ‘barriers’ continue to limit the development of novel antibiotics with innovative characteristics despite intensified international efforts.2. Reinvigorating the antibiotic pipeline requires a holistic package of incentives.3. Ensuring timely access to new and existing antibiotics is critical.4. Improving access to effective antibiotics requires both short- and longer-term measures.5. The EU has a major role to play both in combatting antimicrobial resistance (AMR) and in contributing to global solutions.

 Thông tin dữ liệu nguồn

 Thư viện  Ký hiệu xếp giá  Dữ liệu nguồn
Tổ chức y tế thế giới
https://iris.who.int/handle/10665/369638